血液管理系統市場 - 全球產業規模、佔有率、趨勢、機會及按類型、最終用戶、地區和競爭格局分類的預測（2021-2031年）

全球血液管理系統市場預計將從 2025 年的 163.2 億美元成長到 2031 年的 252.9 億美元，複合年成長率為 7.57%。

該領域涵蓋旨在管理整個血液供應鏈的綜合硬體和軟體解決方案，從捐血招募、血液採集和處理到庫存管理和輸血安全。推動這一成長的關鍵因素包括慢性血液疾病治療中對血液成分的需求不斷成長，以及透過高效的庫存管理減少廢棄物的必要性。此外，需要緊急輸血的創傷事件增多，也促使醫療機構實施這些自動化工作流程，以確保血液製品的快速且準確地輸送。

然而，實施這些大規模數位化平台所需的大量資本投入嚴重阻礙了市場擴張，這往往會對小規模醫療機構的預算造成巨大壓力。此外，管理岌岌可危的血液供應所帶來的營運難題也進一步加劇了這項財務障礙。美國血液中心協會 (ABC) 2025 年的數據顯示，25% 的受監測機構報告稱其庫存水平不足一天，這凸顯了這些系統所提供的精準資源最佳化能力的迫切需求。

市場促進因素

在全球範圍內，慢性疾病和創傷導致的緊急情況日益增多，這成為推動市場發展的主要因素，也凸顯了建立能夠高效調動和分配有限血液資源的系統的重要性。隨著醫療機構努力滿足血液疾病患者治療和緊急轉運的需求，捐血量與臨床需求之間的差距持續擴大。這種脫節在發展中地區尤為嚴重。世界衛生組織（世衛組織）2025年5月發布的《血液安全與供應狀況》報告指出，有60個國家每千人捐血不足10份，凸顯了提高每單位血液效用的技術的重要性。

同時，自動化血液管理解決方案的快速技術進步正透過提高營運效率來變革整個產業。醫院和血站正積極採用整合平台，實現捐血合格和庫存管理的自動化，從而減少人為錯誤並控制成本。這種數位化轉型也清楚地體現在主要產業參與者的財務表現中。例如，Haemonetics 在 2025 年年度報告（2025 年 5 月）中指出，其醫院業務收入成長了 23.7%，這主要得益於血液管理技術的應用。此外，CSL Limited 報告稱，2025 年淨利潤達到 33 億美元，這主要得益於全球對高效管理血漿療法的持續需求。

市場挑戰

實施整合血液管理系統需要大量的初期投資，這給市場成長帶來了巨大障礙，尤其對於財務柔軟性有限的小規模醫療機構而言更是如此。這些數位化平台不僅需要大量的軟體和自動化硬體投入，還需要與現有醫院資訊系統進行複雜的整合。對許多機構而言，這種財務負擔構成了一大障礙，迫使它們儘管面臨營運風險，但仍依賴人工操作、分散的傳統方法。因此，管理者不得不優先考慮緊迫的臨床人員成本，而非基礎設施升級，這大大減緩了這些自動化庫存監控解決方案的普及速度。

這種經濟壓力體現在醫療保健產業利潤率的下降，直接減少了可用於技術引進的可用資金。根據美國醫院協會 (AHA) 2025 年的數據，人事費用約佔醫院總營運支出的 56%，嚴重限制了系統性改善的預算。由於這種嚴峻的財務環境，儘管血液管理系統能夠提高效率，但其初始成本門檻有效地將許多潛在買家拒之門外，最終減緩了全球成長動能。

市場趨勢

將人工智慧和機器學習技術應用於預測性庫存分析，從根本上改變了血庫管理供不應求和產品過期之間微妙平衡的方式。這些系統以動態演算法取代了靜態的歷史平均值，這些演算法能夠考慮季節性波動和創傷患者趨勢，使血庫能夠以前所未有的精度最佳化存量基準。這項變革對於最大限度地減少短效血小板和紅血球的浪費，同時確保緊急輸血的可用性至關重要。這項技術的應用效果是可以量化的：根據美國血庫協會 (AABB) 2024 年 8 月發表的題為《血庫中的人工智慧和資料科學》的報導，一家醫院血庫實施的混合計算模型使存量基準降低了約 40%，並實現了 43% 的成本節約。

此外，採用物聯網智慧冷凍技術和低溫運輸監控系統已成為確保血液製品在儲存和運輸過程中保持物理完整性的關鍵趨勢。與傳統冷凍系統不同，這些智慧型系統利用遠端感測器即時檢測溫度偏差，防止敏感血漿和生物檢體劣化。該技術還透過先進的壓縮機控制最佳化電力消耗，有助於實現醫療基礎設施的永續性目標。根據海爾生物醫療2024年1月發布的新聞稿顯示，該公司新推出的物聯網超低溫冷凍庫技術在確保血站樣本活性的同時，實現了50%的節能效果。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球血液管理系統市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（捐血管理模組、輸血服務模組、庫存管理、捐血計畫管理、篩檢和檢測、報告和分析、整合和互通性、其他）
  • 按最終使用者（血庫、醫院、門診護理中心等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美血液管理系統市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲血液管理系統市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區血液管理系統市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲血液管理系統市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲血液管理系統市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球血液管理系統市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT SA
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, SA
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Blood Management System Market is projected to expand from USD 16.32 Billion in 2025 to USD 25.29 Billion by 2031, registering a CAGR of 7.57%. This sector encompasses comprehensive hardware and software solutions designed to oversee the entire blood supply chain, ranging from donor recruitment and collection processing to inventory management and transfusion safety. Key factors propelling this growth include the increasing demand for blood components to manage chronic hematological conditions and the imperative to minimize waste through efficient inventory control. Furthermore, the rising volume of trauma incidents necessitating emergency transfusions is driving healthcare facilities to implement these automated workflows to ensure the rapid and accurate availability of blood products.

However, market expansion is significantly hindered by the high capital expenditure required to deploy these extensive digital platforms, which often strains the budgets of smaller healthcare providers. This financial barrier is aggravated by the operational difficulties involved in managing unstable blood supplies. According to data from America's Blood Centers in 2025, 25 percent of monitored centers reported operating with critical inventory levels of one day or less, highlighting the urgent need for the precise resource optimization capabilities that these systems provide.

Market Driver

The escalating global prevalence of chronic illnesses and trauma emergencies acts as a major catalyst for the market, creating a pressing need for systems that can efficiently mobilize and distribute scarce blood resources. As healthcare providers struggle to meet the demands of treating hematological disorders and emergency casualties, the gap between donor collection and clinical demand continues to widen. This discrepancy is particularly severe in developing regions; the World Health Organization's May 2025 update on 'Blood safety and availability' noted that 60 nations collected fewer than 10 donations per 1,000 people, emphasizing the critical importance of technologies that maximize the utility of every collected unit.

Simultaneously, rapid technological advancements in automated blood management solutions are transforming the sector by improving operational efficiency. Hospitals and blood centers are aggressively adopting integrated platforms to automate donor qualification and inventory tracking, thereby mitigating human error and controlling costs. This shift towards digitalization is evident in the performance of major industry players. For instance, Haemonetics reported in its 'Fiscal 2025 Annual Report' (May 2025) a 23.7 percent revenue increase in its Hospital business, driven largely by the adoption of blood management technologies. Furthermore, CSL Limited reported a net profit of $3.3 billion in 2025, underpinned by the sustained global demand for efficiently managed plasma therapies.

Market Challenge

The substantial upfront capital required to deploy integrated blood management systems serves as a severe obstruction to market growth, particularly for smaller healthcare facilities with limited financial flexibility. These digital platforms necessitate significant expenditure not only for the software and automated hardware but also for the complex integration into existing hospital information systems. For many institutions, this financial burden is prohibitive, forcing them to rely on manual or fragmented legacy methods despite the operational risks. Consequently, the adoption rate of these automated inventory oversight solutions slows significantly, as administrators are compelled to prioritize immediate clinical staffing costs over infrastructure upgrades.

This economic pressure is further evidenced by tightening profit margins across the healthcare sector, which directly reduces the disposable capital available for technological acquisition. According to the American Hospital Association in 2025, labor costs accounted for approximately 56 percent of total hospital operating expenses, leaving a strictly limited budget for systemic improvements. This intense fiscal strain means that although blood management systems offer efficiency gains, the initial cost barrier effectively locks a large segment of potential buyers out of the market, thereby flattening the global growth trajectory.

Market Trends

The integration of AI and Machine Learning for predictive inventory analytics is fundamentally reshaping how blood centers manage the delicate balance between supply shortages and product expiration. By replacing static historical averages with dynamic algorithms that account for seasonal fluctuations and trauma trends, these systems allow facilities to optimize stock levels with unprecedented precision. This shift is critical for minimizing the discard rates of short-shelf-life platelets and red blood cells while ensuring availability for emergency transfusions. The impact of this technological adoption is quantifiable; according to an AABB article from August 2024 titled 'AI and Data Sciences in Blood Banking', a hybrid computation model deployed for hospital blood banking reduced inventory levels by almost 40 percent and led to a cost reduction of 43 percent.

Additionally, the deployment of IoT-enabled smart refrigeration and cold chain monitoring is emerging as a vital trend to guarantee the physical integrity of blood products during storage and transport. Unlike traditional refrigeration, these smart systems utilize continuous remote sensors to detect temperature excursions in real-time, preventing the spoilage of sensitive plasma and biological samples. This technology also addresses sustainability goals within healthcare infrastructure by optimizing power consumption through advanced compressor regulation. According to Haier Biomedical's January 2024 newsletter, the company's new IoT-enabled ultra-low temperature freezer technology demonstrated a 50 percent energy saving capability while ensuring precise sample viability for blood stations.

Key Market Players

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT S.A.
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

Report Scope

In this report, the Global Blood Management System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management System Market, By Type

• Donor Management Module
• Transfusion Service Module
• Inventory Management
• Donation Scheduling
• Screening & Testing
• Reporting & Analytics
• Integration & Interoperability
• Others

Blood Management System Market, By End User

• Blood Banks
• Hospitals
• Ambulatory Care Centers
• Others

Blood Management System Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Management System Market.

Available Customizations:

Global Blood Management System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Management System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Donor Management Module, Transfusion Service Module, Inventory Management, Donation Scheduling, Screening & Testing, Reporting & Analytics, Integration & Interoperability, Others)
  • 5.2.2. By End User (Blood Banks, Hospitals, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Blood Management System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Blood Management System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Blood Management System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Blood Management System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Management System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. France Blood Management System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Blood Management System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Blood Management System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Blood Management System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia Pacific Blood Management System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Management System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Blood Management System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Blood Management System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Blood Management System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Blood Management System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Middle East & Africa Blood Management System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Management System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Blood Management System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Blood Management System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. South America Blood Management System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Management System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Blood Management System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Blood Management System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Management System Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cerner Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Haemonetics Corporation
• 15.3. Telvent GIT S.A.
• 15.4. Terumo Corporation
• 15.5. Fresenius SE & Co. KGaA
• 15.6. Grifols, S.A.
• 15.7. Baxter International Inc.
• 15.8. Stryker Corporation
• 15.9. Becton, Dickinson and Company
• 15.10. Biolife Solutions, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer